<!DOCTYPE html>
<html lang="it">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>O2-O3-AHT for Fibromyalgia | Consensus Manual</title>
    <style>
        * {
            margin: 0;
            padding: 0;
            box-sizing: border-box;
        }

        :root {
            --primary: #2c5f7c;
            --secondary: #4a9eba;
            --accent: #e74c3c;
            --success: #27ae60;
            --warning: #f39c12;
            --text-dark: #2c3e50;
            --text-light: #ecf0f1;
            --bg-light: #f8f9fa;
            --bg-white: #ffffff;
        }

        body {
            font-family: 'Segoe UI', Tahoma, Geneva, Verdana, sans-serif;
            line-height: 1.6;
            color: var(--text-dark);
            overflow-x: hidden;
        }

        /* Navigation */
        nav {
            position: fixed;
            top: 0;
            width: 100%;
            background: linear-gradient(135deg, var(--primary), var(--secondary));
            padding: 1rem 0;
            box-shadow: 0 2px 10px rgba(0,0,0,0.1);
            z-index: 1000;
        }

        nav .container {
            max-width: 1200px;
            margin: 0 auto;
            display: flex;
            justify-content: space-between;
            align-items: center;
            padding: 0 2rem;
        }

        nav .logo {
            color: var(--text-light);
            font-size: 1.5rem;
            font-weight: bold;
            text-decoration: none;
        }

        nav ul {
            list-style: none;
            display: flex;
            gap: 2rem;
        }

        nav ul li a {
            color: var(--text-light);
            text-decoration: none;
            transition: color 0.3s;
            font-weight: 500;
        }

        nav ul li a:hover {
            color: var(--warning);
        }

        .mobile-menu {
            display: none;
            color: var(--text-light);
            font-size: 1.5rem;
            cursor: pointer;
        }

        /* Hero Section */
        .hero {
            margin-top: 70px;
            background: linear-gradient(135deg, var(--primary) 0%, var(--secondary) 100%);
            color: var(--text-light);
            padding: 6rem 2rem;
            text-align: center;
        }

        .hero h1 {
            font-size: 3rem;
            margin-bottom: 1rem;
            animation: fadeInDown 1s;
        }

        .hero p {
            font-size: 1.3rem;
            max-width: 800px;
            margin: 0 auto 2rem;
            opacity: 0.9;
        }

        .hero .authors {
            font-size: 1.1rem;
            margin-top: 1rem;
            opacity: 0.8;
        }

        .cta-buttons {
            display: flex;
            gap: 1rem;
            justify-content: center;
            margin-top: 2rem;
        }

        .btn {
            padding: 1rem 2rem;
            border: none;
            border-radius: 50px;
            font-size: 1rem;
            cursor: pointer;
            transition: all 0.3s;
            text-decoration: none;
            display: inline-block;
        }

        .btn-primary {
            background: var(--accent);
            color: white;
        }

        .btn-primary:hover {
            background: #c0392b;
            transform: translateY(-3px);
            box-shadow: 0 5px 15px rgba(231, 76, 60, 0.3);
        }

        .btn-secondary {
            background: transparent;
            color: white;
            border: 2px solid white;
        }

        .btn-secondary:hover {
            background: white;
            color: var(--primary);
        }

        /* Container */
        .container {
            max-width: 1200px;
            margin: 0 auto;
            padding: 0 2rem;
        }

        /* Sections */
        section {
            padding: 5rem 2rem;
        }

        section:nth-child(even) {
            background: var(--bg-light);
        }

        .section-title {
            font-size: 2.5rem;
            color: var(--primary);
            margin-bottom: 1rem;
            text-align: center;
        }

        .section-subtitle {
            font-size: 1.2rem;
            color: #7f8c8d;
            text-align: center;
            margin-bottom: 3rem;
            max-width: 700px;
            margin-left: auto;
            margin-right: auto;
        }

        /* Cards */
        .cards {
            display: grid;
            grid-template-columns: repeat(auto-fit, minmax(300px, 1fr));
            gap: 2rem;
            margin-top: 3rem;
        }

        .card {
            background: var(--bg-white);
            padding: 2rem;
            border-radius: 15px;
            box-shadow: 0 5px 20px rgba(0,0,0,0.1);
            transition: all 0.3s;
            cursor: pointer;
        }

        .card:hover {
            transform: translateY(-10px);
            box-shadow: 0 10px 30px rgba(0,0,0,0.15);
        }

        .card-icon {
            font-size: 3rem;
            margin-bottom: 1rem;
        }

        .card h3 {
            color: var(--primary);
            margin-bottom: 1rem;
            font-size: 1.5rem;
        }

        .card p {
            color: #555;
            line-height: 1.8;
        }

        /* Timeline */
        .timeline {
            position: relative;
            max-width: 900px;
            margin: 3rem auto;
        }

        .timeline::before {
            content: '';
            position: absolute;
            left: 50%;
            transform: translateX(-50%);
            width: 4px;
            height: 100%;
            background: var(--secondary);
        }

        .timeline-item {
            margin-bottom: 3rem;
            position: relative;
        }

        .timeline-item:nth-child(odd) {
            padding-right: 50%;
            text-align: right;
        }

        .timeline-item:nth-child(even) {
            padding-left: 50%;
            text-align: left;
        }

        .timeline-content {
            background: var(--bg-white);
            padding: 2rem;
            border-radius: 10px;
            box-shadow: 0 3px 15px rgba(0,0,0,0.1);
            position: relative;
        }

        .timeline-item::after {
            content: '';
            position: absolute;
            top: 20px;
            width: 20px;
            height: 20px;
            background: var(--accent);
            border: 4px solid var(--bg-white);
            border-radius: 50%;
            left: 50%;
            transform: translateX(-50%);
            z-index: 1;
        }

        .timeline-content h3 {
            color: var(--primary);
            margin-bottom: 0.5rem;
        }

        .timeline-content .phase {
            display: inline-block;
            background: var(--accent);
            color: white;
            padding: 0.3rem 1rem;
            border-radius: 20px;
            font-size: 0.9rem;
            margin-bottom: 1rem;
        }

        /* Stats */
        .stats {
            display: grid;
            grid-template-columns: repeat(auto-fit, minmax(200px, 1fr));
            gap: 2rem;
            text-align: center;
            margin: 3rem 0;
        }

        .stat-box {
            background: var(--bg-white);
            padding: 2rem;
            border-radius: 15px;
            box-shadow: 0 5px 20px rgba(0,0,0,0.1);
        }

        .stat-number {
            font-size: 3rem;
            font-weight: bold;
            color: var(--accent);
            display: block;
        }

        .stat-label {
            color: #7f8c8d;
            font-size: 1rem;
            margin-top: 0.5rem;
        }

        /* Accordion */
        .accordion {
            max-width: 900px;
            margin: 3rem auto;
        }

        .accordion-item {
            background: var(--bg-white);
            margin-bottom: 1rem;
            border-radius: 10px;
            overflow: hidden;
            box-shadow: 0 3px 10px rgba(0,0,0,0.1);
        }

        .accordion-header {
            padding: 1.5rem;
            cursor: pointer;
            display: flex;
            justify-content: space-between;
            align-items: center;
            background: var(--primary);
            color: white;
            transition: background 0.3s;
        }

        .accordion-header:hover {
            background: var(--secondary);
        }

        .accordion-header h3 {
            margin: 0;
            font-size: 1.2rem;
        }

        .accordion-icon {
            font-size: 1.5rem;
            transition: transform 0.3s;
        }

        .accordion-item.active .accordion-icon {
            transform: rotate(180deg);
        }

        .accordion-content {
            max-height: 0;
            overflow: hidden;
            transition: max-height 0.3s ease;
            padding: 0 1.5rem;
        }

        .accordion-item.active .accordion-content {
            max-height: 2000px;
            padding: 1.5rem;
        }

        /* Protocol Visual */
        .protocol-visual {
            background: linear-gradient(135deg, #667eea 0%, #764ba2 100%);
            color: white;
            padding: 3rem;
            border-radius: 20px;
            margin: 3rem 0;
            text-align: center;
        }

        .protocol-steps {
            display: grid;
            grid-template-columns: repeat(auto-fit, minmax(150px, 1fr));
            gap: 2rem;
            margin-top: 2rem;
        }

        .protocol-step {
            text-align: center;
        }

        .protocol-step-number {
            width: 60px;
            height: 60px;
            background: white;
            color: #667eea;
            border-radius: 50%;
            display: flex;
            align-items: center;
            justify-content: center;
            font-size: 1.5rem;
            font-weight: bold;
            margin: 0 auto 1rem;
        }

        /* Safety Alert */
        .safety-alert {
            background: linear-gradient(135deg, #ff6b6b, #ee5a6f);
            color: white;
            padding: 2rem;
            border-radius: 15px;
            margin: 3rem 0;
            border-left: 5px solid #c0392b;
        }

        .safety-alert h3 {
            display: flex;
            align-items: center;
            gap: 1rem;
            margin-bottom: 1rem;
        }

        .safety-alert-icon {
            font-size: 2rem;
        }

        /* Footer */
        footer {
            background: var(--text-dark);
            color: var(--text-light);
            padding: 3rem 2rem;
            text-align: center;
        }

        footer .footer-content {
            max-width: 1200px;
            margin: 0 auto;
        }

        footer h3 {
            margin-bottom: 1rem;
        }

        footer .footer-links {
            display: flex;
            justify-content: center;
            gap: 2rem;
            margin: 2rem 0;
            flex-wrap: wrap;
        }

        footer a {
            color: var(--secondary);
            text-decoration: none;
            transition: color 0.3s;
        }

        footer a:hover {
            color: var(--warning);
        }

        /* Animations */
        @keyframes fadeInDown {
            from {
                opacity: 0;
                transform: translateY(-30px);
            }
            to {
                opacity: 1;
                transform: translateY(0);
            }
        }

        @keyframes fadeInUp {
            from {
                opacity: 0;
                transform: translateY(30px);
            }
            to {
                opacity: 1;
                transform: translateY(0);
            }
        }

        .fade-in {
            animation: fadeInUp 1s;
        }

        /* Scroll Progress Bar */
        .progress-bar {
            position: fixed;
            top: 70px;
            left: 0;
            height: 4px;
            background: var(--accent);
            width: 0%;
            z-index: 999;
            transition: width 0.1s;
        }

        /* Table styles */
        .responsive-table {
            overflow-x: auto;
            margin: 2rem 0;
        }

        table {
            width: 100%;
            border-collapse: collapse;
            background: white;
            box-shadow: 0 3px 10px rgba(0,0,0,0.1);
            border-radius: 10px;
            overflow: hidden;
        }

        th {
            background: var(--primary);
            color: white;
            padding: 1rem;
            text-align: left;
        }

        td {
            padding: 1rem;
            border-bottom: 1px solid #ecf0f1;
        }

        tr:hover {
            background: var(--bg-light);
        }

        /* Biomarker visualization */
        .biomarker-viz {
            display: grid;
            grid-template-columns: repeat(auto-fit, minmax(250px, 1fr));
            gap: 2rem;
            margin: 3rem 0;
        }

        .biomarker-card {
            background: white;
            padding: 1.5rem;
            border-radius: 15px;
            box-shadow: 0 3px 15px rgba(0,0,0,0.1);
        }

        .biomarker-card h4 {
            color: var(--primary);
            margin-bottom: 1rem;
        }

        .progress-meter {
            height: 10px;
            background: #ecf0f1;
            border-radius: 10px;
            overflow: hidden;
            margin: 1rem 0;
        }

        .progress-meter-fill {
            height: 100%;
            background: linear-gradient(90deg, var(--accent), var(--success));
            transition: width 1s ease;
        }

        /* Responsive */
        @media (max-width: 768px) {
            nav .container {
                padding: 0 1rem;
            }

            nav ul {
                display: none;
            }

            .mobile-menu {
                display: block;
            }

            nav ul.active {
                display: flex;
                flex-direction: column;
                position: absolute;
                top: 100%;
                left: 0;
                width: 100%;
                background: var(--primary);
                padding: 1rem;
                gap: 1rem;
            }

            .hero {
                padding: 4rem 1rem;
            }

            .hero h1 {
                font-size: 1.8rem;
            }

            .hero p {
                font-size: 1rem;
            }

            .section-title {
                font-size: 2rem;
            }

            .section-subtitle {
                font-size: 1rem;
            }

            .timeline::before {
                left: 30px;
            }

            .timeline-item:nth-child(odd),
            .timeline-item:nth-child(even) {
                padding-left: 80px;
                padding-right: 0;
                text-align: left;
            }

            .timeline-item::after {
                left: 30px;
            }

            .cta-buttons {
                flex-direction: column;
            }

            section {
                padding: 3rem 1rem;
            }

            .container {
                padding: 0 1rem;
            }

            .cards {
                grid-template-columns: 1fr;
            }

            .stats {
                grid-template-columns: 1fr 1fr;
            }

            .protocol-steps {
                grid-template-columns: 1fr;
            }

            table {
                font-size: 0.9rem;
            }

            th, td {
                padding: 0.7rem 0.5rem;
            }

            .biomarker-viz {
                grid-template-columns: 1fr;
            }

            body {
                overflow-x: hidden;
            }

            * {
                max-width: 100%;
            }

            .accordion-content ul {
                margin-left: 1rem;
            }
        }

        @media (max-width: 480px) {
            .hero h1 {
                font-size: 1.5rem;
            }

            .stats {
                grid-template-columns: 1fr;
            }

            .stat-number {
                font-size: 2.5rem;
            }

            .btn {
                padding: 0.8rem 1.5rem;
                font-size: 0.9rem;
            }
        }
    </style>
</head>
<body>
    <!-- Progress Bar -->
    <div class="progress-bar" id="progressBar"></div>

    <!-- Navigation -->
    <nav>
        <div class="container">
            <a href="#" class="logo">ü´Å O‚ÇÇ-O‚ÇÉ-AHT Manual</a>
            <ul id="navMenu">
                <li><a href="#intro">Introduction</a></li>
                <li><a href="#pathophysiology">Pathophysiology</a></li>
                <li><a href="#mechanism">Mechanism</a></li>
                <li><a href="#protocol">Protocol</a></li>
                <li><a href="#safety">Safety</a></li>
                <li><a href="#flowchart">Flowchart</a></li>
                <li><a href="#resources">Resources</a></li>
            </ul>
            <div class="mobile-menu" id="mobileMenu">‚ò∞</div>
        </div>
    </nav>

    <!-- Hero Section -->
    <section class="hero">
        <div class="container">
            <h1>Oxygen-Ozone Autohemotherapy for Fibromyalgia</h1>
            <p>A Comprehensive Consensus Manual on Mechanism, Protocol, and Biomarker-Guided Therapy</p>
            <p class="authors">Edited by Roberto Casale, MD & Piercarlo Sarzi-Puttini, MD</p>
            <div class="cta-buttons">
                <a href="#protocol" class="btn btn-primary">View Protocol</a>
                <a href="#resources" class="btn btn-secondary">Download Manual</a>
            </div>
        </div>
    </section>

    <!-- Introduction -->
    <section id="intro">
        <div class="container">
            <h2 class="section-title">Understanding Fibromyalgia</h2>
            <p class="section-subtitle">A complex chronic pain disorder affecting 2-4% of the global population</p>
            
            <div class="stats">
                <div class="stat-box">
                    <span class="stat-number">2-4%</span>
                    <span class="stat-label">Global Prevalence</span>
                </div>
                <div class="stat-box">
                    <span class="stat-number">7:1</span>
                    <span class="stat-label">Female:Male Ratio</span>
                </div>
                <div class="stat-box">
                    <span class="stat-number">50%</span>
                    <span class="stat-label">With Small Fiber Pathology</span>
                </div>
                <div class="stat-box">
                    <span class="stat-number">&lt;50%</span>
                    <span class="stat-label">Response to Current Meds</span>
                </div>
            </div>

            <div class="cards">
                <div class="card">
                    <div class="card-icon">üéØ</div>
                    <h3>Diagnostic Evolution</h3>
                    <p>From 1990 ACR tender points to 2016 criteria focusing on widespread pain index (WPI) and symptom severity scale (SSS), now classified under ICD-11 chronic primary pain.</p>
                </div>
                <div class="card">
                    <div class="card-icon">üß¨</div>
                    <h3>Oxidative Stress</h3>
                    <p>Elevated MDA, AOPP, and reduced antioxidant capacity (TAC, GSH, SOD, GPx) indicate profound cellular redox imbalance as a core pathophysiological mechanism.</p>
                </div>
                <div class="card">
                    <div class="card-icon">‚ö°</div>
                    <h3>Mitochondrial Dysfunction</h3>
                    <p>Impaired Complex I activity, reduced ATP synthesis, and cellular energy deficits contribute to fatigue and exercise intolerance characteristic of FM.</p>
                </div>
            </div>
        </div>
    </section>

    <!-- Pathophysiology -->
    <section id="pathophysiology">
        <div class="container">
            <h2 class="section-title">Pathophysiology & Small Fiber Pathology</h2>
            <p class="section-subtitle">Multiple interconnected mechanisms underlying FM symptoms</p>

            <div class="cards">
                <div class="card">
                    <div class="card-icon">üî¨</div>
                    <h3>Small Fiber Neuropathy</h3>
                    <p>40-50% of FM patients show reduced intraepidermal nerve fiber density (IENFD) on skin biopsy, providing objective structural pathology.</p>
                </div>
                <div class="card">
                    <div class="card-icon">üß†</div>
                    <h3>Central Sensitization</h3>
                    <p>Amplification of pain signals in the CNS, aberrant pain processing, and neuroinflammation with glial activation.</p>
                </div>
                <div class="card">
                    <div class="card-icon">üî•</div>
                    <h3>Neuroinflammation</h3>
                    <p>Elevated IL-6, TNF-Œ±, IL-1Œ≤, and hsCRP creating pro-inflammatory microenvironment that damages nerve fibers.</p>
                </div>
            </div>

            <div class="responsive-table" style="margin-top: 3rem;">
                <table>
                    <thead>
                        <tr>
                            <th>Biomarker</th>
                            <th>Normal Range</th>
                            <th>FM Typical</th>
                            <th>Clinical Significance</th>
                        </tr>
                    </thead>
                    <tbody>
                        <tr>
                            <td><strong>MDA</strong></td>
                            <td>&lt;2.0 Œºmol/L</td>
                            <td>2.5-4.5 Œºmol/L</td>
                            <td>Lipid peroxidation marker</td>
                        </tr>
                        <tr>
                            <td><strong>TAC</strong></td>
                            <td>1.3-1.8 mmol/L</td>
                            <td>0.8-1.2 mmol/L</td>
                            <td>Total antioxidant capacity</td>
                        </tr>
                        <tr>
                            <td><strong>hsCRP</strong></td>
                            <td>&lt;1 mg/L</td>
                            <td>3-8 mg/L</td>
                            <td>Systemic inflammation</td>
                        </tr>
                        <tr>
                            <td><strong>GSH:GSSG</strong></td>
                            <td>&gt;10:1</td>
                            <td>5:1 to 8:1</td>
                            <td>Cellular redox status</td>
                        </tr>
                    </tbody>
                </table>
            </div>
        </div>
    </section>

    <!-- Nrf2 Mechanism -->
    <section id="mechanism">
        <div class="container">
            <h2 class="section-title">Nrf2 Pathway & Hormetic Mechanism</h2>
            <p class="section-subtitle">How O‚ÇÇ-O‚ÇÉ-AHT triggers beneficial adaptive responses</p>

            <div class="protocol-visual">
                <h3>Hormetic Principle</h3>
                <p>Low-dose oxidative stress activates Nrf2, triggering upregulation of 200+ cytoprotective genes</p>
                <div class="protocol-steps">
                    <div class="protocol-step">
                        <div class="protocol-step-number">1</div>
                        <h4>Ozone Contact</h4>
                        <p>Generates LOPs (4-HNE, MDA)</p>
                    </div>
                    <div class="protocol-step">
                        <div class="protocol-step-number">2</div>
                        <h4>Keap1 Oxidation</h4>
                        <p>Releases Nrf2</p>
                    </div>
                    <div class="protocol-step">
                        <div class="protocol-step-number">3</div>
                        <h4>Nuclear Translocation</h4>
                        <p>Nrf2 enters nucleus</p>
                    </div>
                    <div class="protocol-step">
                        <div class="protocol-step-number">4</div>
                        <h4>ARE Binding</h4>
                        <p>Activates gene transcription</p>
                    </div>
                    <div class="protocol-step">
                        <div class="protocol-step-number">5</div>
                        <h4>Enzyme Production</h4>
                        <p>SOD, CAT, GPx, HO-1 ‚Üë</p>
                    </div>
                </div>
            </div>

            <h3 style="text-align: center; margin: 3rem 0 2rem; color: var(--primary);">Temporal Dynamics</h3>
            <div class="timeline">
                <div class="timeline-item">
                    <div class="timeline-content">
                        <span class="phase">Immediate Phase</span>
                        <h3>0-30 minutes</h3>
                        <p>Ozone-derived LOPs (4-HNE) covalently modify Keap1 cysteine residues, disrupting Keap1-Nrf2 interaction. MAPK activation phosphorylates Nrf2, facilitating nuclear translocation.</p>
                    </div>
                </div>
                <div class="timeline-item">
                    <div class="timeline-content">
                        <span class="phase">Acute Phase</span>
                        <h3>Minutes to 6 hours</h3>
                        <p>Stabilized Nrf2 accumulates and translocates to nucleus, heterodimerizing with Maf proteins and binding to AREs. Transcriptional activation of Nrf2 gene battery begins.</p>
                    </div>
                </div>
                <div class="timeline-item">
                    <div class="timeline-content">
                        <span class="phase">Adaptive Phase</span>
                        <h3>6-72 hours</h3>
                        <p>Peak expression of antioxidant enzymes (5-10 fold increases). Maximum cellular stress resistance and anti-inflammatory capacity. Redox homeostasis restoration.</p>
                    </div>
                </div>
                <div class="timeline-item">
                    <div class="timeline-content">
                        <span class="phase">Resolution Phase</span>
                        <h3>3-14 days</h3>
                        <p>Nrf2 returns to baseline but cytoprotective proteins persist due to long half-lives. Enhanced stress resistance maintained, providing basis for inter-treatment intervals.</p>
                    </div>
                </div>
            </div>

            <div class="biomarker-viz">
                <div class="biomarker-card">
                    <h4>MDA Reduction</h4>
                    <p>20-40% decrease</p>
                    <div class="progress-meter">
                        <div class="progress-meter-fill" style="width: 35%"></div>
                    </div>
                    <small>Indicates reduced lipid peroxidation</small>
                </div>
                <div class="biomarker-card">
                    <h4>TAC Increase</h4>
                    <p>20-40% increase</p>
                    <div class="progress-meter">
                        <div class="progress-meter-fill" style="width: 30%"></div>
                    </div>
                    <small>Enhanced antioxidant reserves</small>
                </div>
                <div class="biomarker-card">
                    <h4>hsCRP Decrease</h4>
                    <p>30-50% reduction</p>
                    <div class="progress-meter">
                        <div class="progress-meter-fill" style="width: 40%"></div>
                    </div>
                    <small>Reduced systemic inflammation</small>
                </div>
                <div class="biomarker-card">
                    <h4>Pain Reduction</h4>
                    <p>30-40% decrease</p>
                    <div class="progress-meter">
                        <div class="progress-meter-fill" style="width: 35%"></div>
                    </div>
                    <small>VAS score improvement</small>
                </div>
            </div>
        </div>
    </section>

    <!-- Protocol -->
    <section id="protocol">
        <div class="container">
            <h2 class="section-title">Optimized Treatment Protocol</h2>
            <p class="section-subtitle">Biomarker-guided, person-tailored approach</p>

            <div class="accordion">
                <div class="accordion-item">
                    <div class="accordion-header">
                        <h3>Pre-Treatment Assessment</h3>
                        <span class="accordion-icon">‚ñº</span>
                    </div>
                    <div class="accordion-content">
                        <h4 style="color: var(--accent); margin: 1.5rem 0 1rem;">Patient Phenotyping:</h4>
                        <ul style="line-height: 2; margin-left: 2rem;">
                            <li>High oxidative stress (MDA >2.5 Œºmol/L)</li>
                            <li>Inflammatory phenotype (hsCRP >3 mg/L)</li>
                            <li>Mitochondrial dysfunction (fatigue, exercise intolerance)</li>
                            <li>Small fiber pathology (burning pain, dysesthesias)</li>
                        </ul>
                        <h4 style="color: var(--accent); margin: 1.5rem 0 1rem;">Mandatory Screening:</h4>
                        <ul style="line-height: 2; margin-left: 2rem;">
                            <li><strong>G6PD Activity</strong> - ABSOLUTE REQUIREMENT (deficiency = contraindication)</li>
                            <li>Complete blood count (CBC)</li>
                            <li>Comprehensive metabolic panel (CMP)</li>
                            <li>Thyroid function (TSH, free T4)</li>
                        </ul>
                        <h4 style="color: var(--accent); margin: 1.5rem 0 1rem;">Baseline Biomarkers:</h4>
                        <ul style="line-height: 2; margin-left: 2rem;">
                            <li>Oxidative stress: MDA, AOPP, 8-OHdG</li>
                            <li>Antioxidant capacity: TAC, SOD, GPx</li>
                            <li>Inflammation: hsCRP, IL-6, TNF-Œ±</li>
                            <li>Glutathione status: GSH, GSH:GSSG ratio</li>
                        </ul>
                    </div>
                </div>

                <div class="accordion-item">
                    <div class="accordion-header">
                        <h3>Intensive Phase (4-6 weeks)</h3>
                        <span class="accordion-icon">‚ñº</span>
                    </div>
                    <div class="accordion-content">
                        <h4 style="color: var(--success); margin: 1rem 0;">Core Parameters:</h4>
                        <ul style="line-height: 2; margin-left: 2rem;">
                            <li><strong>Frequency:</strong> 2-3 sessions/week (spaced 2-4 days apart)</li>
                            <li><strong>Duration:</strong> 4-6 weeks total</li>
                            <li><strong>Total sessions:</strong> 8-18 (based on severity)</li>
                            <li><strong>Blood volume:</strong> 100-150 mL (adjust for patient size)</li>
                            <li><strong>Reinfusion rate:</strong> 1 drop/second, max 90 drops/minute</li>
                        </ul>
                        <h4 style="color: var(--success); margin: 1.5rem 0 1rem;">Ozone Concentration (Progressive Escalation):</h4>
                        <ul style="line-height: 2; margin-left: 2rem;">
                            <li><strong>Initial sessions (1-3):</strong> 10-20 Œºg/mL</li>
                            <li><strong>Middle sessions (4-8):</strong> 20-30 Œºg/mL</li>
                            <li><strong>Later sessions (9-15):</strong> 30-40 Œºg/mL</li>
                            <li><strong>Maximum:</strong> 40 Œºg/mL (hormetic zone ceiling)</li>
                        </ul>
                        <h4 style="color: var(--success); margin: 1.5rem 0 1rem;">Interim Assessments:</h4>
                        <ul style="line-height: 2; margin-left: 2rem;">
                            <li><strong>Week 2-3:</strong> Pain/function, tolerance check</li>
                            <li><strong>Week 4-5:</strong> Comprehensive reassessment + PGIC</li>
                            <li><strong>Week 6:</strong> Full outcome + biomarker repeat</li>
                        </ul>
                    </div>
                </div>

                <div class="accordion-item">
                    <div class="accordion-header">
                        <h3>Maintenance Phase (6-12+ months)</h3>
                        <span class="accordion-icon">‚ñº</span>
                    </div>
                    <div class="accordion-content">
                        <h4 style="color: var(--warning); margin: 1rem 0;">Frequency Options:</h4>
                        <ul style="line-height: 2; margin-left: 2rem;">
                            <li><strong>Fixed schedule:</strong> Monthly (every 3-4 weeks) for first 6 months</li>
                            <li><strong>Symptom-triggered:</strong> When pain increases ‚â•20-30% for ‚â•1 week</li>
                            <li><strong>Biomarker-guided:</strong> When MDA rises >20% or TAC declines >15%</li>
                        </ul>
                        <h4 style="color: var(--warning); margin: 1.5rem 0 1rem;">Response Criteria to Proceed:</h4>
                        <ul style="line-height: 2; margin-left: 2rem;">
                            <li>Pain reduction ‚â•30% OR VAS decrease ‚â•2 points</li>
                            <li>FIQ reduction ‚â•20% OR decrease ‚â•15 points</li>
                            <li>PGIC: "much improved" or "very much improved"</li>
                            <li>Favorable biomarker changes (‚ÜìMDA, ‚ÜëTAC, ‚ÜìhsCRP)</li>
                        </ul>
                        <p style="margin-top: 1.5rem; padding: 1rem; background: var(--bg-light); border-radius: 8px;">
                            <strong>Duration:</strong> Typically 6-12 months; some patients require extended maintenance (12-24 months) or long-term low-frequency therapy (every 2-3 months).
                        </p>
                    </div>
                </div>

                <div class="accordion-item">
                    <div class="accordion-header">
                        <h3>Nutritional & Adjunctive Therapies</h3>
                        <span class="accordion-icon">‚ñº</span>
                    </div>
                    <div class="accordion-content">
                        <h4 style="color: var(--primary); margin: 1rem 0;">Mediterranean Diet:</h4>
                        <ul style="line-height: 2; margin-left: 2rem;">
                            <li>Fruits & vegetables: 5-9 servings daily</li>
                            <li>Fish: 2-3 servings per week</li>
                            <li>Olive oil: 3-4 tablespoons daily</li>
                            <li>Nuts: ~30 grams daily</li>
                            <li>Red meat: Limited to ‚â§1 serving weekly</li>
                        </ul>
                        <h4 style="color: var(--primary); margin: 1.5rem 0 1rem;">Supplements:</h4>
                        <ul style="line-height: 2; margin-left: 2rem;">
                            <li><strong>Coenzyme Q10:</strong> 200-300 mg daily (ubiquinol form) ‚úÖ</li>
                            <li><strong>Hydration:</strong> 2-3 liters water daily ‚úÖ</li>
                            <li><strong>Avoid during intensive phase:</strong> High-dose Vit C (>1000mg), Vit E (>400 IU), glutathione 24-48h before/after sessions ‚ö†Ô∏è</li>
                        </ul>
                        <h4 style="color: var(--primary); margin: 1.5rem 0 1rem;">Non-Pharmacological:</h4>
                        <ul style="line-height: 2; margin-left: 2rem;">
                            <li>Exercise: Aerobic 2-3x/week, aquatic therapy</li>
                            <li>CBT or ACT for pain catastrophizing</li>
                            <li>Sleep hygiene optimization</li>
                            <li>Patient education on self-management</li>
                        </ul>
                    </div>
                </div>
            </div>
        </div>
    </section>

    <!-- Safety -->
    <section id="safety">
        <div class="container">
            <h2 class="section-title">Safety & Contraindications</h2>
            <p class="section-subtitle">Ensuring patient safety through proper screening and monitoring</p>

            <div class="safety-alert">
                <h3>
                    <span class="safety-alert-icon">‚ö†Ô∏è</span>
                    CRITICAL: Mandatory G6PD Screening
                </h3>
                <p style="font-size: 1.1rem; line-height: 1.8;">
                    Glucose-6-phosphate dehydrogenase (G6PD) deficiency is an ABSOLUTE CONTRAINDICATION to ozone therapy. This genetic condition affects ~400 million people globally with highest prevalence in Mediterranean, African, Asian, and Middle Eastern populations. G6PD screening MUST be performed before any treatment‚Äîdeficiency can cause life-threatening hemolytic crisis.
                </p>
            </div>

            <div style="display: grid; grid-template-columns: 1fr 1fr; gap: 2rem; margin: 3rem 0;">
                <div style="background: #ffe6e6; padding: 2rem; border-radius: 15px; border-left: 5px solid var(--accent);">
                    <h3 style="color: var(--accent); margin-bottom: 1rem;">üõë Absolute Contraindications</h3>
                    <ul style="line-height: 2;">
                        <li><strong>G6PD deficiency / Favism</strong></li>
                        <li>Acute hemolytic anemia</li>
                        <li>Active bleeding / coagulopathies</li>
                        <li>Severe thrombocytopenia (&lt;50k/ŒºL)</li>
                        <li>Active hyperthyroidism</li>
                        <li>Pregnancy</li>
                        <li>Recent MI (&lt;3 months)</li>
                        <li>Patent foramen ovale</li>
                    </ul>
                </div>

                <div style="background: #fff4e6; padding: 2rem; border-radius: 15px; border-left: 5px solid var(--warning);">
                    <h3 style="color: var(--warning); margin-bottom: 1rem;">‚ö° Relative Contraindications</h3>
                    <ul style="line-height: 2;">
                        <li>Uncontrolled hypertension (BP &gt;180/110)</li>
                        <li>Active anticoagulation therapy</li>
                        <li>Significant anemia (Hb &lt;10 g/dL)</li>
                        <li>Active malignancy (consult oncologist)</li>
                        <li>Neurodegenerative disorders (consult neurologist)</li>
                        <li>Seizure disorder (theoretical concern)</li>
                    </ul>
                </div>
            </div>

            <h3 style="text-align: center; margin: 3rem 0 2rem; color: var(--primary);">Common Side Effects (5-15% incidence)</h3>
            <div class="cards">
                <div class="card">
                    <div class="card-icon">üò¥</div>
                    <h3>Transient Fatigue</h3>
                    <p><strong>Incidence:</strong> 5-10%<br>
                    <strong>Duration:</strong> 12-24 hours<br>
                    <strong>Management:</strong> Rest, hydration, reassurance</p>
                </div>
                <div class="card">
                    <div class="card-icon">ü§ï</div>
                    <h3>Mild Headache</h3>
                    <p><strong>Incidence:</strong> 4-8%<br>
                    <strong>Cause:</strong> Vasodilation<br>
                    <strong>Management:</strong> Slower reinfusion, hydration</p>
                </div>
                <div class="card">
                    <div class="card-icon">üíâ</div>
                    <h3>Injection Site Discomfort</h3>
                    <p><strong>Incidence:</strong> 3-5%<br>
                    <strong>Type:</strong> Minor bruising/tenderness<br>
                    <strong>Management:</strong> Standard venipuncture care</p>
                </div>
            </div>

            <div style="background: var(--bg-white); padding: 2rem; border-radius: 15px; margin: 3rem 0; box-shadow: 0 3px 15px rgba(0,0,0,0.1);">
                <h3 style="color: var(--success); margin-bottom: 1.5rem; text-align: center;">‚úÖ Minimizing Side Effects</h3>
                <div style="display: grid; grid-template-columns: repeat(auto-fit, minmax(250px, 1fr)); gap: 1.5rem;">
                    <div>
                        <strong style="color: var(--primary);">‚Ä¢ Start Low:</strong>
                        <p>Begin with 10-20 Œºg/mL for initial sessions</p>
                    </div>
                    <div>
                        <strong style="color: var(--primary);">‚Ä¢ Hydrate:</strong>
                        <p>2-3 glasses water before treatment</p>
                    </div>
                    <div>
                        <strong style="color: var(--primary);">‚Ä¢ Slow Reinfusion:</strong>
                        <p>1 drop/second maximum rate</p>
                    </div>
                    <div>
                        <strong style="color: var(--primary);">‚Ä¢ Light Meal:</strong>
                        <p>Eat 1-2 hours before (avoid fasting)</p>
                    </div>
                </div>
            </div>
        </div>
    </section>

    <!-- Interactive Flowchart Section -->
    <section id="flowchart" style="background: var(--bg-light);">
        <div class="container">
            <h2 class="section-title">Treatment Decision Flowchart</h2>
            <p class="section-subtitle">Interactive guide for patient selection and protocol optimization</p>
            
            <div style="background: white; padding: 2rem; border-radius: 20px; box-shadow: 0 5px 20px rgba(0,0,0,0.1); margin: 3rem 0;">
                <div id="flowchart-container" style="max-width: 100%; overflow-x: auto;">
                    <!-- SVG Flowchart will be rendered here -->
                </div>
            </div>

            <div style="text-align: center; margin-top: 2rem;">
                <button class="btn btn-primary" onclick="resetFlowchart()">Reset Flowchart</button>
                <button class="btn btn-secondary" onclick="exportFlowchart()">Export as PDF</button>
            </div>
        </div>
    </section>

    <!-- Clinical Evidence -->
    <section id="evidence">
        <div class="container">
            <h2 class="section-title">Clinical Evidence</h2>
            <p class="section-subtitle">Published studies demonstrating efficacy and safety</p>

            <div class="cards">
                <div class="card">
                    <div class="card-icon">üìä</div>
                    <h3>Hidalgo-Tall√≥n et al. 2013</h3>
                    <p><strong>Design:</strong> Prospective case series (n=24)<br>
                    <strong>Protocol:</strong> 20 sessions/10 weeks, 40 Œºg/mL<br>
                    <strong>Results:</strong> 41% pain reduction, 31% FIQ improvement<br>
                    <strong>Follow-up:</strong> Benefits sustained at 6 months</p>
                </div>
                <div class="card">
                    <div class="card-icon">üìà</div>
                    <h3>Tirelli et al. 2019-2022</h3>
                    <p><strong>Design:</strong> Case series (65‚Üí200 patients)<br>
                    <strong>Results:</strong> Significant pain reduction (10-PI-NRS)<br>
                    <strong>Safety:</strong> Adverse effects &lt;5%<br>
                    <strong>Conclusion:</strong> Excellent real-world tolerability</p>
                </div>
                <div class="card">
                    <div class="card-icon">üî¨</div>
                    <h3>Eldemrdash et al. 2024</h3>
                    <p><strong>Design:</strong> Prospective RCT<br>
                    <strong>Population:</strong> Chronic MSK pain + mitochondrial dysfunction<br>
                    <strong>Results:</strong> Significant clinical improvements<br>
                    <strong>Relevance:</strong> Validates oxidative stress mechanism</p>
                </div>
            </div>

            <div style="background: linear-gradient(135deg, #667eea 0%, #764ba2 100%); color: white; padding: 3rem; border-radius: 20px; margin: 3rem 0; text-align: center;">
                <h3 style="font-size: 2rem; margin-bottom: 1rem;">Biomarker Validation</h3>
                <p style="font-size: 1.2rem; opacity: 0.9; margin-bottom: 2rem;">Objective molecular evidence supporting clinical improvements</p>
                <div style="display: grid; grid-template-columns: repeat(auto-fit, minmax(200px, 1fr)); gap: 2rem;">
                    <div>
                        <div style="font-size: 2.5rem; font-weight: bold;">‚Üì20-40%</div>
                        <p>MDA (oxidative damage)</p>
                    </div>
                    <div>
                        <div style="font-size: 2.5rem; font-weight: bold;">‚Üë20-40%</div>
                        <p>TAC (antioxidant capacity)</p>
                    </div>
                    <div>
                        <div style="font-size: 2.5rem; font-weight: bold;">‚Üì30-50%</div>
                        <p>hsCRP (inflammation)</p>
                    </div>
                    <div>
                        <div style="font-size: 2.5rem; font-weight: bold;">‚Üë15-50%</div>
                        <p>SOD activity</p>
                    </div>
                </div>
            </div>
        </div>
    </section>

    <!-- Resources -->
    <section id="resources">
        <div class="container">
            <h2 class="section-title">Resources & Downloads</h2>
            <p class="section-subtitle">Access comprehensive materials for clinicians and patients</p>

            <div style="display: grid; grid-template-columns: repeat(auto-fit, minmax(300px, 1fr)); gap: 2rem; margin: 3rem 0;">
                <div class="card" style="background: linear-gradient(135deg, #667eea 0%, #764ba2 100%); color: white;">
                    <div class="card-icon">üìò</div>
                    <h3>Full Consensus Manual</h3>
                    <p>Complete 12,000+ word comprehensive manual with all protocols, mechanisms, and guidelines</p>
                    <button class="btn btn-secondary" style="margin-top: 1rem; width: 100%;">Download PDF</button>
                </div>

                <div class="card" style="background: linear-gradient(135deg, #f093fb 0%, #f5576c 100%); color: white;">
                    <div class="card-icon">üìã</div>
                    <h3>Quick Reference Guide</h3>
                    <p>Condensed protocol summary with checklists for clinical practice</p>
                    <button class="btn btn-secondary" style="margin-top: 1rem; width: 100%;">Download PDF</button>
                </div>

                <div class="card" style="background: linear-gradient(135deg, #4facfe 0%, #00f2fe 100%); color: white;">
                    <div class="card-icon">üë•</div>
                    <h3>Patient Education Handout</h3>
                    <p>Patient-friendly guide explaining treatment, expectations, and dietary recommendations</p>
                    <button class="btn btn-secondary" style="margin-top: 1rem; width: 100%;">Download PDF</button>
                </div>

                <div class="card">
                    <div class="card-icon">üîó</div>
                    <h3>International Organizations</h3>
                    <ul style="line-height: 2; margin-top: 1rem; list-style: none;">
                        <li>üåê <a href="#" style="color: var(--primary);">ISCO3 - International Scientific Committee</a></li>
                        <li>üåê <a href="#" style="color: var(--primary);">SIOOT - Italian Society O2-O3 Therapy</a></li>
                        <li>üåê <a href="#" style="color: var(--primary);">Madrid Declaration on Ozone Therapy</a></li>
                    </ul>
                </div>

                <div class="card">
                    <div class="card-icon">üìö</div>
                    <h3>Key References</h3>
                    <ul style="line-height: 2; margin-top: 1rem; list-style: none; font-size: 0.9rem;">
                        <li>‚Ä¢ Hidalgo-Tall√≥n et al. 2013 (Rev Soc Esp Dolor)</li>
                        <li>‚Ä¢ Tirelli et al. 2022 (Eur Rev Med Pharmacol Sci)</li>
                        <li>‚Ä¢ Petrikonis et al. 2024 (Pharmaceutics)</li>
                        <li>‚Ä¢ Cordero et al. 2013 (CoQ10 in FM)</li>
                    </ul>
                </div>

                <div class="card">
                    <div class="card-icon">üìß</div>
                    <h3>Contact & Support</h3>
                    <p style="margin-top: 1rem;">
                        <strong>Corresponding Author:</strong><br>
                        Roberto Casale, MD<br>
                        Opusmedica, Piacenza, Italy<br>
                        üìß roberto.casale@opusmedica.it
                    </p>
                </div>
            </div>

            <div style="background: var(--bg-light); padding: 3rem; border-radius: 20px; margin: 3rem 0; text-align: center;">
                <h3 style="color: var(--primary); margin-bottom: 1rem;">Research Priorities</h3>
                <p style="max-width: 800px; margin: 0 auto 2rem; line-height: 1.8;">
                    While preliminary evidence is promising, adequately powered double-blind, sham-controlled RCTs are urgently needed to definitively establish efficacy, optimize protocols, identify predictive biomarkers, and validate mechanistic hypotheses.
                </p>
                <div style="display: flex; gap: 1rem; justify-content: center; flex-wrap: wrap;">
                    <span style="background: white; padding: 0.7rem 1.5rem; border-radius: 25px; box-shadow: 0 2px 8px rgba(0,0,0,0.1);">
                        ‚úÖ Nrf2 nuclear translocation studies
                    </span>
                    <span style="background: white; padding: 0.7rem 1.5rem; border-radius: 25px; box-shadow: 0 2px 8px rgba(0,0,0,0.1);">
                        ‚úÖ Peripheral nerve regeneration trials
                    </span>
                    <span style="background: white; padding: 0.7rem 1.5rem; border-radius: 25px; box-shadow: 0 2px 8px rgba(0,0,0,0.1);">
                        ‚úÖ Neuroimaging studies
                    </span>
                    <span style="background: white; padding: 0.7rem 1.5rem; border-radius: 25px; box-shadow: 0 2px 8px rgba(0,0,0,0.1);">
                        ‚úÖ Long-term safety registries
                    </span>
                    <span style="background: white; padding: 0.7rem 1.5rem; border-radius: 25px; box-shadow: 0 2px 8px rgba(0,0,0,0.1);">
                        ‚úÖ Cost-effectiveness analyses
                    </span>
                </div>
            </div>
        </div>
    </section>

    <!-- Footer -->
    <footer>
        <div class="footer-content">
            <h3>A Consensus Manual for the Use of O‚ÇÇ-O‚ÇÉ-AHT in Fibromyalgia</h3>
            <p style="margin: 1rem 0; opacity: 0.8;">
                Edited by Roberto Casale & Piercarlo Sarzi-Puttini<br>
                Opusmedica, Persons Care & Research, Piacenza, Italy
            </p>
            
            <div style="display: flex; justify-content: center; gap: 2rem; margin: 2rem 0; flex-wrap: wrap; align-items: center;">
                <a href="https://www.opusmedica.org" target="_blank" rel="noopener" style="display: flex; align-items: center; gap: 0.5rem; font-size: 1.1rem;">
                    üè• <span>Opusmedica.org</span>
                </a>
                <a href="https://www.instagram.com/opus_medica" target="_blank" rel="noopener" style="display: flex; align-items: center; gap: 0.5rem; font-size: 1.1rem;">
                    üì∏ <span>@opus_medica</span>
                </a>
                <a href="https://youtu.be/5hH_tDWM0fE" target="_blank" rel="noopener" style="display: flex; align-items: center; gap: 0.5rem; font-size: 1.1rem;">
                    ‚ñ∂Ô∏è <span>Video Tutorial</span>
                </a>
            </div>
            
            <div class="footer-links">
                <a href="#intro">Introduction</a>
                <a href="#pathophysiology">Pathophysiology</a>
                <a href="#mechanism">Mechanism</a>
                <a href="#protocol">Protocol</a>
                <a href="#safety">Safety</a>
                <a href="#flowchart">Flowchart</a>
                <a href="#resources">Resources</a>
            </div>

            <p style="margin-top: 2rem; font-size: 0.9rem; opacity: 0.6;">
                ¬© 2025 Opusmedica NPO & Foundation Ermete, Milan, Italy. All rights reserved.<br>
                This manual represents current evidence and expert consensus. Protocols should be adapted based on individual patient characteristics and clinical judgment.
            </p>

            <p style="margin-top: 1rem; font-size: 0.85rem; opacity: 0.5;">
                Website created for educational purposes. Not a substitute for professional medical advice.<br>
                Website developed by <strong>2M Digital Consulting srls</strong>
            </p>
        </div>
    </footer>

    <script>
        // Mobile menu toggle
        const mobileMenu = document.getElementById('mobileMenu');
        const navMenu = document.getElementById('navMenu');

        mobileMenu.addEventListener('click', () => {
            navMenu.classList.toggle('active');
        });

        // Smooth scrolling for navigation links
        document.querySelectorAll('a[href^="#"]').forEach(anchor => {
            anchor.addEventListener('click', function (e) {
                e.preventDefault();
                const target = document.querySelector(this.getAttribute('href'));
                if (target) {
                    target.scrollIntoView({
                        behavior: 'smooth',
                        block: 'start'
                    });
                    // Close mobile menu if open
                    navMenu.classList.remove('active');
                }
            });
        });

        // Scroll progress bar
        window.addEventListener('scroll', () => {
            const winScroll = document.body.scrollTop || document.documentElement.scrollTop;
            const height = document.documentElement.scrollHeight - document.documentElement.clientHeight;
            const scrolled = (winScroll / height) * 100;
            document.getElementById('progressBar').style.width = scrolled + '%';
        });

        // Accordion functionality
        const accordionHeaders = document.querySelectorAll('.accordion-header');

        accordionHeaders.forEach(header => {
            header.addEventListener('click', () => {
                const item = header.parentElement;
                const wasActive = item.classList.contains('active');
                
                // Close all accordion items
                document.querySelectorAll('.accordion-item').forEach(i => {
                    i.classList.remove('active');
                });
                
                // Open clicked item if it wasn't active
                if (!wasActive) {
                    item.classList.add('active');
                }
            });
        });

        // Interactive Flowchart
        function createFlowchart() {
            const container = document.getElementById('flowchart-container');
            if (!container) return;

            const flowchartHTML = `
                <svg viewBox="0 0 800 1200" style="width: 100%; height: auto; max-width: 800px; margin: 0 auto; display: block;">
                    <!-- Patient Presentation -->
                    <rect x="250" y="20" width="300" height="80" rx="10" fill="#2c5f7c" />
                    <text x="400" y="50" text-anchor="middle" fill="white" font-size="16" font-weight="bold">
                        <tspan x="400" dy="0">FM Patient Presentation</tspan>
